2024 - Innovative Approaches in Metabolic Dysfunction-Associated Steatohepatitis Clinical Research
Date2024-10-10
Deadline2024-10-10
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Pharmaceutical
Topics/Call fo Papers
The evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH) research demands precise and reliable methodologies to ensure accurate data collection and analysis. In this upcoming webinar, the expert speakers will provide a deep dive into the imaging and histological techniques that are foundational to metabolic dysfunction-associated steatohepatitis studies. Attendees will also gain insights into the operational and medical strategies that streamline the research process, ensuring that studies are conducted with the highest level of quality and consistency.
Learn from Medpace experts, as they explore strategies to enhance operational efficiency, focusing on ensuring seamless integration of data throughout the study process β from sample collection to final analysis. They will also cover best practices for the preparation and standardization of liver biopsy samples, essential for accurate histological evaluation. This will include detailed guidance on resolving connectivity issues related to transitioning from traditional microscopy to whole-slide digital images. Additionally, the webinar will discuss the evolution of read paradigms in histology, from single to multi-read techniques, and the implications this has for diagnostic accuracy and research outcomes in metabolic dysfunction-associated steatohepatitis.
This webinar will thus offer a comprehensive overview from sample acquisition of biopsy samples to final endpoint analysis β emphasizing the importance of maintaining consistency across tissue batches over extended study periods, which is crucial for the integrity of metabolic dysfunction-associated steatohepatitis studies. Register for this webinar today.
Keywords: Drug Development, Liver, Clinical Research, CRO, Liver Disease, NASH, NAFLD, Therapeutic Areas, Liver Cancer, Fatty Liver, Non-Alcoholic Fatty Liver Disease, MASH
Learn from Medpace experts, as they explore strategies to enhance operational efficiency, focusing on ensuring seamless integration of data throughout the study process β from sample collection to final analysis. They will also cover best practices for the preparation and standardization of liver biopsy samples, essential for accurate histological evaluation. This will include detailed guidance on resolving connectivity issues related to transitioning from traditional microscopy to whole-slide digital images. Additionally, the webinar will discuss the evolution of read paradigms in histology, from single to multi-read techniques, and the implications this has for diagnostic accuracy and research outcomes in metabolic dysfunction-associated steatohepatitis.
This webinar will thus offer a comprehensive overview from sample acquisition of biopsy samples to final endpoint analysis β emphasizing the importance of maintaining consistency across tissue batches over extended study periods, which is crucial for the integrity of metabolic dysfunction-associated steatohepatitis studies. Register for this webinar today.
Keywords: Drug Development, Liver, Clinical Research, CRO, Liver Disease, NASH, NAFLD, Therapeutic Areas, Liver Cancer, Fatty Liver, Non-Alcoholic Fatty Liver Disease, MASH
Other CFPs
- Navigating Complexity: Tailoring Cell-Based Bioassays for Advanced Therapeutics
- PROTACs: Breaking Boundaries in Drug Discovery
- Charting the Course: Strategies for Therapeutic Vaccine Study Success
- Sequencing Cells without Killing Them Using Subcellular Biopsies
- Boost CRISPR Editing Efficiency Using Optimized sgRNA and HDR Template Design
Last modified: 2024-09-17 05:14:55